| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
Journal of the American Society of Nephrology, Vol 7, 2495-2508, Copyright © 1996 by American Society of Nephrology
REVIEWS |
AA Eddy
Progressive interstitial fibrosis accompanied by loss of renal tubules and interstitial capillaries typifies all progressive renal diseases. Dynamic and complex, the process evidently overlaps with matrix remodeling; it may even be reversible. The interstitial fibrous tissue comprises several normal and novel matrix proteins, proteoglycans, and glycoproteins. Interstitial myofibroblasts are a major site of matrix protein overproduction, although resident fibroblasts, tubular cells, and inflammatory cells may contribute. Inadequate matrix degradation also appears to contribute to the fibrogenic process. Two protease cascades, the metalloproteinases and the plasminogen activator/ plasmin family of serine proteases, are implicated in the turnover of interstitial matrix proteins; upregulated expression of protease inhibitors has been observed in each. Increased tissue inhibitor of metalloproteinase-1 and plasminogen activator inhibitor-1 levels suggest that the intrinsic renal activity of the metalloproteinases and serine proteases are inhibited while matrix proteins accumulate in the interstitium. Several signals that may direct the interstitial fibrogenic process have been identified, but not yet proved to cause it. Upregulated expression of transforming growth factor beta-1, the proteotypic fibrogenic cytokine, has been observed in experimental and human models; it probably does not act alone. There may be supportive roles for platelet-derived growth factor, interleukin-1, basic fibroblast growth factor, angiotensin II, and endothelin-1. Although it is not known why interstitial fibrosis compromises renal function, atrophy of renal tubules may be pivotal. Ischemic necrosis and/or apoptosis may generate nonfunctioning atubular and sclerotic glomeruli. Future studies must delineate the molecular basis of the differences between renal repair and renal destruction by fibrosis, two processes that share many common features.
This article has been cited by other articles:
![]() |
E. M. Zeisberg, S. E. Potenta, H. Sugimoto, M. Zeisberg, and R. Kalluri Fibroblasts in Kidney Fibrosis Emerge via Endothelial-to-Mesenchymal Transition J. Am. Soc. Nephrol., December 1, 2008; 19(12): 2282 - 2287. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Stoessel, A. Paliege, F. Theilig, F. Addabbo, B. Ratliff, J. Waschke, D. Patschan, M. S. Goligorsky, and S. Bachmann Indolent course of tubulointerstitial disease in a mouse model of subpressor, low-dose nitric oxide synthase inhibition Am J Physiol Renal Physiol, September 1, 2008; 295(3): F717 - F725. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kitamura, Y. Isaka, Y. Takabatake, R. Imamura, C. Suzuki, S. Takahara, and E. Imai Nonerythropoietic derivative of erythropoietin protects against tubulointerstitial injury in a unilateral ureteral obstruction model Nephrol. Dial. Transplant., May 1, 2008; 23(5): 1521 - 1528. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Li, K. S. Hering-Smith, E. E. Simon, and V. Batuman Myeloma light chains induce epithelial-mesenchymal transition in human renal proximal tubule epithelial cells Nephrol. Dial. Transplant., March 1, 2008; 23(3): 860 - 870. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Pollack, R. Sarkozi, Z. Banki, E. Feifel, S. Wehn, G. Gstraunthaler, H. Stoiber, G. Mayer, R. Montesano, F. Strutz, et al. Oncostatin M-induced effects on EMT in human proximal tubular cells: differential role of ERK signaling Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1714 - F1726. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zhang, Z. Jia, X. Guo, and T. Yang Aldosterone induces epithelial-mesenchymal transition via ROS of mitochondrial origin Am J Physiol Renal Physiol, September 1, 2007; 293(3): F723 - F731. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. I. Chaudhary, G. J. Roth, F. Hilberg, J. Muller-Quernheim, A. Prasse, G. Zissel, A. Schnapp, and J. E. Park Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis Eur. Respir. J., May 1, 2007; 29(5): 976 - 985. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Bauvois, N. Mothu, J. Nguyen, T. Nguyen-Khoa, L.-H. Noel, and P. Jungers Specific changes in plasma concentrations of matrix metalloproteinase-2 and -9, TIMP-1 and TGF-{beta}1 in patients with distinct types of primary glomerulonephritis Nephrol. Dial. Transplant., April 1, 2007; 22(4): 1115 - 1122. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Meldrum, R. Misseri, P. Metcalfe, C. A. Dinarello, K. L. Hile, and D. R. Meldrum TNF-{alpha} neutralization ameliorates obstruction-induced renal fibrosis and dysfunction Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2007; 292(4): R1456 - R1464. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Y. Li, F. F. Hou, X. Zhang, P. Y. Chen, S. X. Liu, J. X. Feng, Z. Q. Liu, Y. X. Shan, G. B. Wang, Z. M. Zhou, et al. Advanced Oxidation Protein Products Accelerate Renal Fibrosis in a Remnant Kidney Model J. Am. Soc. Nephrol., February 1, 2007; 18(2): 528 - 538. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. O'Riordan, N. Mendelev, S. Patschan, D. Patschan, J. Eskander, L. Cohen-Gould, P. Chander, and M. S. Goligorsky Chronic NOS inhibition actuates endothelial-mesenchymal transformation Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H285 - H294. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Vagin, E. Tokhtaeva, and G. Sachs The Role of the beta1 Subunit of the Na,K-ATPase and Its Glycosylation in Cell-Cell Adhesion J. Biol. Chem., December 22, 2006; 281(51): 39573 - 39587. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zhang, M.-H. Wang, Z. Dong, and T. Yang Prostaglandin E2 is a potent inhibitor of epithelial-to-mesenchymal transition: interaction with hepatocyte growth factor Am J Physiol Renal Physiol, December 1, 2006; 291(6): F1323 - F1331. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zhang, Z. Dong, and T. Yang Prostaglandin D2 inhibits TGF-beta1-induced epithelial-to-mesenchymal transition in MDCK cells Am J Physiol Renal Physiol, December 1, 2006; 291(6): F1332 - F1342. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zhang, D. Fraser, and A. Phillips ERK, p38, and Smad Signaling Pathways Differentially Regulate Transforming Growth Factor-{beta}1 Autoinduction in Proximal Tubular Epithelial Cells Am. J. Pathol., October 1, 2006; 169(4): 1282 - 1293. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Furuichi, J.-L. Gao, and P. M. Murphy Chemokine Receptor CX3CR1 Regulates Renal Interstitial Fibrosis after Ischemia-Reperfusion Injury Am. J. Pathol., August 1, 2006; 169(2): 372 - 387. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. M. D. Pecly, R. G. Goncalves, E. P. Rangel, C. M. Takiya, F. S. Taboada, C. A. Martinusso, M. S. G. Pavao, and M. Leite Jr Effects of low molecular weight heparin in obstructed kidneys: decrease of collagen, fibronectin and TGF-{beta}, and increase of chondroitin/dermatan sulfate proteoglycans and macrophage infiltration Nephrol. Dial. Transplant., May 1, 2006; 21(5): 1212 - 1222. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Kim, J. I. Yang, M. H. Jung, J. S. Hwa, K.-R. Kang, D. J. Park, G. S. Roh, G. J. Cho, W. S. Choi, and S.-H. Chang Heme Oxygenase-1 Protects Rat Kidney from Ureteral Obstruction via an Antiapoptotic Pathway J. Am. Soc. Nephrol., May 1, 2006; 17(5): 1373 - 1381. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. I. Chaudhary, A. Schnapp, and J. E. Park Pharmacologic Differentiation of Inflammation and Fibrosis in the Rat Bleomycin Model Am. J. Respir. Crit. Care Med., April 1, 2006; 173(7): 769 - 776. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Omata, H. Taniguchi, D. Koya, K. Kanasaki, R. Sho, Y. Kato, R. Kojima, M. Haneda, and N. Inomata N-Acetyl-Seryl-Aspartyl-Lysyl-Proline Ameliorates the Progression of Renal Dysfunction and Fibrosis in WKY Rats with Established Anti-Glomerular Basement Membrane Nephritis J. Am. Soc. Nephrol., March 1, 2006; 17(3): 674 - 685. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-L. Lin, R.-H. Chen, Y.-M. Chen, W.-C. Chiang, C.-F. Lai, K.-D. Wu, and T.-J. Tsai Pentoxifylline Attenuates Tubulointerstitial Fibrosis by Blocking Smad3/4-Activated Transcription and Profibrogenic Effects of Connective Tissue Growth Factor J. Am. Soc. Nephrol., September 1, 2005; 16(9): 2702 - 2713. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Ito, A. Kanehiro, K. Matsumoto, A. Hirano, K. Ono, H. Maruyama, M. Kataoka, T. Nakamura, E. W. Gelfand, and M. Tanimoto Hepatocyte Growth Factor Attenuates Airway Hyperresponsiveness, Inflammation, and Remodeling Am. J. Respir. Cell Mol. Biol., April 1, 2005; 32(4): 268 - 280. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Y. Rhyu, Y. Yang, H. Ha, G. T. Lee, J. S. Song, S.-t. Uh, and H. B. Lee Role of Reactive Oxygen Species in TGF-{beta}1-Induced Mitogen-Activated Protein Kinase Activation and Epithelial-Mesenchymal Transition in Renal Tubular Epithelial Cells J. Am. Soc. Nephrol., March 1, 2005; 16(3): 667 - 675. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Okada, T. Kikuta, T. Kobayashi, T. Inoue, Y. Kanno, M. Takigawa, T. Sugaya, J. B. Kopp, and H. Suzuki Connective Tissue Growth Factor Expressed in Tubular Epithelium Plays a Pivotal Role in Renal Fibrogenesis J. Am. Soc. Nephrol., January 1, 2005; 16(1): 133 - 143. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Samuel, E. N. Unemori, I. Mookerjee, R. A. D. Bathgate, S. L. Layfield, J. Mak, G. W. Tregear, and X.-J. Du Relaxin Modulates Cardiac Fibroblast Proliferation, Differentiation, and Collagen Production and Reverses Cardiac Fibrosis in Vivo Endocrinology, September 1, 2004; 145(9): 4125 - 4133. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Fukasawa, T. Yamamoto, A. Togawa, N. Ohashi, Y. Fujigaki, T. Oda, C. Uchida, K. Kitagawa, T. Hattori, S. Suzuki, et al. Down-regulation of Smad7 expression by ubiquitin-dependent degradation contributes to renal fibrosis in obstructive nephropathy in mice PNAS, June 8, 2004; 101(23): 8687 - 8692. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yokoi, M. Mukoyama, T. Nagae, K. Mori, T. Suganami, K. Sawai, T. Yoshioka, M. Koshikawa, T. Nishida, M. Takigawa, et al. Reduction in Connective Tissue Growth Factor by Antisense Treatment Ameliorates Renal Tubulointerstitial Fibrosis J. Am. Soc. Nephrol., June 1, 2004; 15(6): 1430 - 1440. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Manotham, T. Tanaka, M. Matsumoto, T. Ohse, T. Miyata, R. Inagi, K. Kurokawa, T. Fujita, and M. Nangaku Evidence of Tubular Hypoxia in the Early Phase in the Remnant Kidney Model J. Am. Soc. Nephrol., May 1, 2004; 15(5): 1277 - 1288. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Li, W. Wang, X. R. Huang, M. Oldfield, A. M. Schmidt, M. E. Cooper, and H. Y. Lan Advanced Glycation End Products Induce Tubular Epithelial-Myofibroblast Transition through the RAGE-ERK1/2 MAP Kinase Signaling Pathway Am. J. Pathol., April 1, 2004; 164(4): 1389 - 1397. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Liu Epithelial to Mesenchymal Transition in Renal Fibrogenesis: Pathologic Significance, Molecular Mechanism, and Therapeutic Intervention J. Am. Soc. Nephrol., January 1, 2004; 15(1): 1 - 12. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yamashita, A. Maeshima, I. Kojima, and Y. Nojima Activin A Is a Potent Activator of Renal Interstitial Fibroblasts J. Am. Soc. Nephrol., January 1, 2004; 15(1): 91 - 101. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Gong, A. Rifai, E. M. Tolbert, J. N. Centracchio, and L. D. Dworkin Hepatocyte Growth Factor Modulates Matrix Metalloproteinases and Plasminogen Activator/Plasmin Proteolytic Pathways in Progressive Renal Interstitial Fibrosis J. Am. Soc. Nephrol., December 1, 2003; 14(12): 3047 - 3060. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zeisberg, C. Bottiglio, N. Kumar, Y. Maeshima, F. Strutz, G. A. Muller, and R. Kalluri Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models Am J Physiol Renal Physiol, December 1, 2003; 285(6): F1060 - F1067. [Abstract] [Full Text] |
||||
![]() |
R. Mishra, P. Leahy, and M. S. Simonson Gene expression profile of endothelin-1-induced growth in glomerular mesangial cells Am J Physiol Cell Physiol, November 1, 2003; 285(5): C1109 - C1115. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Praga, C. F. Andrade, J. Luno, M. Arias, R. Poveda, J. Mora, M. V. Prat, F. Rivera, J. M. Galceran, J. M. Ara, et al. Antiproteinuric efficacy of losartan in comparison with amlodipine in non-diabetic proteinuric renal diseases: a double-blind, randomized clinical trial Nephrol. Dial. Transplant., September 1, 2003; 18(9): 1806 - 1813. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lindschau, P. Quass, J. Menne, F. Guler, A. Fiebeler, M. Leitges, F. C. Luft, and H. Haller Glucose-Induced TGF-{beta}1 and TGF-{beta} Receptor-1 Expression in Vascular Smooth Muscle Cells Is Mediated by Protein Kinase C-{alpha} Hypertension, September 1, 2003; 42(3): 335 - 341. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Rossert, B. Fouqueray, and J. J. Boffa Anemia Management and the Delay of Chronic Renal Failure Progression J. Am. Soc. Nephrol., July 1, 2003; 14(90002): S173 - 177. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Y. Lan, W. Mu, N. Tomita, X. R. Huang, J. H. Li, H.-J. Zhu, R. Morishita, and R. J. Johnson Inhibition of Renal Fibrosis by Gene Transfer of Inducible Smad7 Using Ultrasound-Microbubble System in Rat UUO Model J. Am. Soc. Nephrol., June 1, 2003; 14(6): 1535 - 1548. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Zhang, H. Kim, X. Cai, J. M. Lopez-Guisa, C. E. Alpers, Y. Liu, P. Carmeliet, and A. A. Eddy Urokinase Receptor Deficiency Accelerates Renal Fibrosis in Obstructive Nephropathy J. Am. Soc. Nephrol., May 1, 2003; 14(5): 1254 - 1271. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Mason and N. A. Wahab Extracellular Matrix Metabolism in Diabetic Nephropathy J. Am. Soc. Nephrol., May 1, 2003; 14(5): 1358 - 1373. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Masszi, C. Di Ciano, G. Sirokmany, W. T. Arthur, O. D. Rotstein, J. Wang, C. A. G. McCulloch, L. Rosivall, I. Mucsi, and A. Kapus Central role for Rho in TGF-beta 1-induced alpha -smooth muscle actin expression during epithelial-mesenchymal transition Am J Physiol Renal Physiol, May 1, 2003; 284(5): F911 - F924. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Dai, J. Yang, and Y. Liu Transforming Growth Factor-beta 1 Potentiates Renal Tubular Epithelial Cell Death by a Mechanism Independent of Smad Signaling J. Biol. Chem., March 28, 2003; 278(14): 12537 - 12545. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yang and Y. Liu Delayed administration of hepatocyte growth factor reduces renal fibrosis in obstructive nephropathy Am J Physiol Renal Physiol, February 1, 2003; 284(2): F349 - F357. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Herrero-Fresneda, J. Torras, J. M. Cruzado, E. Condom, A. Vidal, M. Riera, N. Lloberas, J. Alsina, and J. M. Grinyo Do Alloreactivity and Prolonged Cold Ischemia Cause Different Elementary Lesions in Chronic Allograft Nephropathy? Am. J. Pathol., January 1, 2003; 162(1): 127 - 137. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Morcos, A. A.R. Sayed, A. Bierhaus, B. Yard, R. Waldherr, W. Merz, I. Kloeting, E. Schleicher, S. Mentz, R. F. Abd el Baki, et al. Activation of Tubular Epithelial Cells in Diabetic Nephropathy Diabetes, December 1, 2002; 51(12): 3532 - 3544. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Klahr and J. Morrissey Obstructive nephropathy and renal fibrosis Am J Physiol Renal Physiol, November 1, 2002; 283(5): F861 - F875. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yang, C. Dai, and Y. Liu Hepatocyte Growth Factor Gene Therapy and Angiotensin II Blockade Synergistically Attenuate Renal Interstitial Fibrosis in Mice J. Am. Soc. Nephrol., October 1, 2002; 13(10): 2464 - 2477. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Kelly, J. L. Wilkinson-Berka, S. D. Ricardo, A. J. Cox, and R. E. Gilbert Progression of tubulointerstitial injury by osteopontin-induced macrophage recruitment in advanced diabetic nephropathy of transgenic (mRen-2)27 rats Nephrol. Dial. Transplant., June 1, 2002; 17(6): 985 - 991. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Li, H.-J. Zhu, X. R. Huang, K. N. Lai, R. J. Johnson, and H. Y. Lan Smad7 Inhibits Fibrotic Effect of TGF-{beta} on Renal Tubular Epithelial Cells by Blocking Smad2 Activation J. Am. Soc. Nephrol., June 1, 2002; 13(6): 1464 - 1472. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Morrissey, G. Guo, K. Moridaira, M. Fitzgerald, R. McCracken, T. Tolley, and S. Klahr Transforming Growth Factor-{beta} Induces Renal Epithelial Jagged-1 Expression in Fibrotic Disease J. Am. Soc. Nephrol., June 1, 2002; 13(6): 1499 - 1508. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zeisberg, Y. Maeshima, B. Mosterman, and R. Kalluri Renal Fibrosis : Extracellular Matrix Microenvironment Regulates Migratory Behavior of Activated Tubular Epithelial Cells Am. J. Pathol., June 1, 2002; 160(6): 2001 - 2008. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yokoi, M. Mukoyama, A. Sugawara, K. Mori, T. Nagae, H. Makino, T. Suganami, K. Yahata, Y. Fujinaga, I. Tanaka, et al. Role of connective tissue growth factor in fibronectin expression and tubulointerstitial fibrosis Am J Physiol Renal Physiol, May 1, 2002; 282(5): F933 - F942. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ben-Yosef, N. Lahat, S. Shapiro, H. Bitterman, and A. Miller Regulation of Endothelial Matrix Metalloproteinase-2 by Hypoxia/Reoxygenation Circ. Res., April 19, 2002; 90(7): 784 - 791. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Remuzzi, P. Ruggenenti, and N. Perico Chronic Renal Diseases: Renoprotective Benefits of Renin-Angiotensin System Inhibition Ann Intern Med, April 16, 2002; 136(8): 604 - 615. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Schaefer, K. Macakova, I. Raslik, M. Micegova, H.-J. Grone, E. Schonherr, H. Robenek, F. G. Echtermeyer, S. Grassel, P. Bruckner, et al. Absence of Decorin Adversely Influences Tubulointerstitial Fibrosis of the Obstructed Kidney by Enhanced Apoptosis and Increased Inflammatory Reaction Am. J. Pathol., March 1, 2002; 160(3): 1181 - 1191. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yang and Y. Liu Blockage of Tubular Epithelial to Myofibroblast Transition by Hepatocyte Growth Factor Prevents Renal Interstitial Fibrosis J. Am. Soc. Nephrol., January 1, 2002; 13(1): 96 - 107. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Suzuki, O. Lopez-Franco, D. Gomez-Garre, N. Tejera, C. Gomez-Guerrero, T. Sugaya, R. Bernal, J. Blanco, L. Ortega, and J. Egido Renal Tubulointerstitial Damage Caused by Persistent Proteinuria Is Attenuated in AT1-Deficient Mice : Role of Endothelin-1 Am. J. Pathol., November 1, 2001; 159(5): 1895 - 1904. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Essig, F. Terzi, M. Burtin, and G. Friedlander Mechanical strains induced by tubular flow affect the phenotype of proximal tubular cells Am J Physiol Renal Physiol, October 1, 2001; 281(4): F751 - F762. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Stahl and D. Felsen Transforming Growth Factor-{beta}, Basement Membrane, and Epithelial-Mesenchymal Transdifferentiation : Implications for Fibrosis in Kidney Disease Am. J. Pathol., October 1, 2001; 159(4): 1187 - 1192. [Full Text] |
||||
![]() |
M. Zeisberg, G. Bonner, Y. Maeshima, P. Colorado, G. A. Muller, F. Strutz, and R. Kalluri Renal Fibrosis : Collagen Composition and Assembly Regulates Epithelial-Mesenchymal Transdifferentiation Am. J. Pathol., October 1, 2001; 159(4): 1313 - 1321. [Abstract] [Full Text] |
||||
![]() |
J. Yang and Y. Liu Dissection of Key Events in Tubular Epithelial to Myofibroblast Transition and Its Implications in Renal Interstitial Fibrosis Am. J. Pathol., October 1, 2001; 159(4): 1465 - 1475. [Abstract] [Full Text] |
||||
![]() |
S. KONDO, S. KAGAMI, H. KIDO, F. STRUTZ, G. A. MULLER, and Y. KURODA Role of Mast Cell Tryptase in Renal Interstitial Fibrosis J. Am. Soc. Nephrol., August 1, 2001; 12(8): 1668 - 1676. [Abstract] [Full Text] [PDF] |
||||
![]() |
|